Futurefuel Corp Dossier - Source-backed chat

Futurefuel Corp

FFNYSE

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)0.89

Intrinsic Value $3.21median of 2 methodsbased on filings through 30 Jun 2026

Market Price $5.02Price as of 1 Oct 2026

OvervaluedIntrinsic value is 36% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $220.2M

Enterprise Value $185.8M

Shares Outstanding 44.1M diluted

Next Earnings Date10 Nov 2026

Last ex-dividend4 Sep 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

FutureFuel Corp. is navigating a complex operational transition as it restarts its core biofuel production segment following a costly six-month shutdown driven by regulatory ambiguity. While Q1 2026 revenue rebounded sharply by 82.2% year-over-year to $32.0 million, the company continues to post significant net losses ($20.6 million in Q1 2026) due to heavy derivative hedging losses ($11.6 million) and storm-related costs. The investment case is supported by a debt-free balance sheet, a flexible manufacturing facility in Batesville, Arkansas, and a major $25 million customer-funded capacity agreement in its high-margin chemicals segment. However, near-term profitability remains highly volatile and dependent on the execution of the biofuel restart and the stabilization of commodity hedging outcomes. Consequently, a Hold recommendation is warranted until consistent positive Adjusted EBITDA is established.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$3.00

Renewed regulatory hurdles or feedstock cost inflation compress biofuel margins, forcing another production slowdown. Continued derivative hedging losses and operational inefficiencies at the Batesville plant drain cash reserves, delaying the commercial roadmap for the chemicals segment and keeping net income deeply negative.

Base CaseCentral scenario

$5.00

The biofuel segment successfully ramps up production toward historical levels under the clarified regulatory framework of the Clean Fuel Production Credit (IRA 45Z). The chemicals segment continues its steady growth, supported by the methacrylate plant expansion and initial customer-funded capital deposits. Hedging losses normalize, allowing the company to achieve positive Adjusted EBITDA for the full year 2026 and gradually narrow net losses.

Scenarios reflect our research view at the research date.

Key Investment Merits

Debt-free balance sheet with solid liquidity, including $22.4 million in cash and cash equivalents as of March 31, 2026.
Strong customer commitment in the chemicals segment, highlighted by a definitive agreement for a $25 million customer-funded capacity addition in 2026.
Flexible manufacturing infrastructure at the Batesville facility, allowing the company to shift capacity between custom chemicals and biofuels based on market conditions.

Key Investment Risks

High exposure to commodity price volatility and complex derivative hedging instruments, which resulted in an $11.6 million loss in Q1 2026.
Dependence on federal regulatory frameworks and tax incentives (such as IRA 45Z and RIN tracking) to maintain biofuel segment profitability.
History of operational disruptions from severe weather events, such as Winter Storm Fern, which added non-recurring repair costs.

Thesis Invalidation Triggers

Failure to achieve positive Adjusted EBITDA for the full year 2026.
A decision to suspend biofuel production again due to unfavorable economics or regulatory changes.
Delays or cancellations in the customer-funded chemicals capacity expansion program.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.